Research programme: viral immunotherapy - Lipid SciencesAlternative Names: Viral immunotherapy research programme - Lipid Sciences
Latest Information Update: 16 Jul 2016
At a glance
- Originator Lipid Sciences
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Coronavirus infections; HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Coronavirus-infections in USA
- 05 Dec 2003 Preclinical trials in Coronavirus infections in USA (unspecified route)